Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
FDMT
FDMT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest FDMT ETF News Today | Earnings, Events & Price Alerts
FDMT News
4D Molecular Therapeutics Grants 23,600 RSUs to New Employees
Jan 17 2026
Globenewswire
Major Stocks Including BlackBerry, FedEx, and Nike Decline in Friday's Pre-Market Trading
Dec 19 2025
Benzinga
4D Molecular Shares Decline Following Initial Trial Results for Cystic Fibrosis Treatment
Dec 17 2025
SeekingAlpha
4D Molecular Therapeutics Reports Positive Interim Data for 4D-710 in Cystic Fibrosis Trial
Dec 17 2025
Globenewswire
4D Molecular Therapeutics Announces Encouraging Interim Phase 1 Results for 4D-710 in Cystic Fibrosis
Dec 17 2025
NASDAQ.COM
4D Molecular Therapeutics Grants 13,800 RSUs to New Employees Under Inducement Plan
Dec 12 2025
Globenewswire
4D Molecular Therapeutics Grants 13,800 RSUs to New Employees Under Inducement Plan
Dec 12 2025
Newsfilter
NovaBridge's Visara Division Names Renowned Ophthalmology Experts as Chief Medical Officer and Chair of Scientific Advisory Board to Advance VIS-101
Nov 21 2025
Newsfilter
NovaBridge's Visara Division Names Renowned Ophthalmology Experts as Chief Medical Officer and Chair of Scientific Advisory Board to Advance VIS-101
Nov 20 2025
Globenewswire
4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer
Nov 17 2025
Yahoo Finance
4DMT Names Kristian Humer as Chief Financial Officer
Nov 17 2025
NASDAQ.COM
4DMT Unveils New Employment Incentive Grants
Nov 14 2025
Newsfilter
Eli Lilly invests in eye care by acquiring gene therapy company Adverum
Oct 24 2025
Reuters
4DMT Unveils New Employment Incentive Grants
Sep 12 2025
Newsfilter
SNY's Gene Therapy for Eye Disease Receives FDA Fast Track Designation
Sep 11 2025
NASDAQ.COM
4D Molecular Therapeutics, Inc. (FDMT) Participates in Morgan Stanley's 23rd Annual Global Healthcare Conference (Transcript)
Sep 09 2025
Newsfilter
Show More News
